Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Geldanomycin
1. 30562-34-6
2. Chebi:5292
3. Nsc-122750
4. Z3k3vj16ku
5. U-29135
6. Mfcd00274570
7. [(3r,5s,6r,7s,8e,10s,11s,12z,14e)-6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] Carbamate
8. Gdm
9. Nsc 122750
10. (4e,6z,8s,9s,10e,12s,13r,14s,16r)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl Carbamate
11. Unii-z3k3vj16ku
12. 1yet
13. [8s-(4e,6z,8r*,9r*,10e,12r*,13s*,14r*,16s*)]-9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione
14. Geldanamycin (9ci)
15. Brn 1633093
16. Geldanamycin [mi]
17. Schembl4154
18. U 29135
19. Bspbio_001073
20. Gtpl9829
21. Dtxsid7042691
22. Geldanamycin Ready Made Solution
23. Schembl13037476
24. Chebi:91381
25. Hms1362e15
26. Hms1792e15
27. Hms1990e15
28. Hms3403e15
29. Bdbm50008059
30. Ei-280
31. Akos024456552
32. Zinc100064834
33. Ccg-208040
34. Db02424
35. Idi1_002122
36. Ncgc00163449-01
37. Ncgc00163449-02
38. 2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9,13-dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, 9-carbamate (8ci)
39. Geldanamycin From Streptomyces Hygroscopicus
40. G0334
41. Sr-05000002266
42. A1-50253
43. J-018017
44. J-521410
45. Sr-05000002266-3
46. Brd-k11528507-001-01-8
47. Geldanamycin, Streptomyces Hygroscopicus - Cas 30562-34-6
48. Geldanamycin From Streptomyces Hygroscopicus, >=98% (hplc), Powder
49. [(3s,5s,6r,7s,8e,10r,11s,12z,14e)-6-hydroxy-5,11,21-trimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] Carbamate
50. [(4e,6z,8s,9s,10e,12s,13r,14s,16r)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] Carbamate
51. 2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, (4e,6z,8s,9s,10e,12s,13r,14s,16r)-
52. 2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-, [8s-(4e,6z,8r*,9r*,10e,12r*,13s*,14r*,16s*)]-
53. Gmy
Molecular Weight | 560.6 g/mol |
---|---|
Molecular Formula | C29H40N2O9 |
XLogP3 | 2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 5 |
Exact Mass | 560.27338086 g/mol |
Monoisotopic Mass | 560.27338086 g/mol |
Topological Polar Surface Area | 164 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 1150 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Cysteine Proteinase Inhibitors
Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)
Antibiotics, Antineoplastic
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
ABOUT THIS PAGE
A Geldanamycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Geldanamycin, including repackagers and relabelers. The FDA regulates Geldanamycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Geldanamycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Geldanamycin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Geldanamycin supplier is an individual or a company that provides Geldanamycin active pharmaceutical ingredient (API) or Geldanamycin finished formulations upon request. The Geldanamycin suppliers may include Geldanamycin API manufacturers, exporters, distributors and traders.
click here to find a list of Geldanamycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Geldanamycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Geldanamycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Geldanamycin GMP manufacturer or Geldanamycin GMP API supplier for your needs.
A Geldanamycin CoA (Certificate of Analysis) is a formal document that attests to Geldanamycin's compliance with Geldanamycin specifications and serves as a tool for batch-level quality control.
Geldanamycin CoA mostly includes findings from lab analyses of a specific batch. For each Geldanamycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Geldanamycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Geldanamycin EP), Geldanamycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Geldanamycin USP).
LOOKING FOR A SUPPLIER?